Release Date: 22/04/14 12:13 Summary: Change in substantial holding from MLM Price Sensitive: No Download Document 109.77KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%